Site Map

Pages

• About
  • Careers
  • Environmental, Social and Governance (ESG)
  • Events
  • Executive Leadership
  • Locations
  • Newsroom
    • Media Coverage
    • Press Releases
  • Partners
  • Quality Commitment
• BioAgilytix: Ihr vielseitiger Bioanalyse Partner
• BioAgilytix: Your Comprehensive Bioanalytical Partner
• Blog
• Blog
  • Assessing Cellular Immunogenicity via ELISpot
  • Best Practices for the Development and Validation of qPCR and ddPCR Assays
  • Bioanalytical challenges for cellular immunogenicity testing using validated ELISpot assays
  • Bioanalytical Strategies for Biomarker Implementation in Clinical Trials
  • Bioanalytical Strategies for Oncolytic Virus Therapeutics
  • Challenges and Strategies for the Bioanalysis of Protein Therapeutics and Biomarkers by LC–MS/MS
  • Challenges and Strategies for the Bioanalysis of Protein Therapeutics and Biomarkers by LC–MS/MS
  • Considerations for Biodistribution and Viral Shedding Assays in Regulated Bioanalysis
  • eChalk Talk: Bioanalytical Strategy for Immunogenicity Assessments of ATMPs
  • eChalk Talk: Bioanalytical Strategy for PK Assessments of ATMPs
  • eChalk Talk: CMC Bioanalytical Control for ATMPs – Challenges and Strategies
  • Flow Cytometry Tools to Support Cellular Therapies
  • Full-Service Bioanalysis of an Immuno-Oncology Program
  • Gyrolab®: Case Studies in Assay Development & Validation
  • Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials
  • Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials
  • Innovations in Microsampling Technologies to Advance Clinical Trial Design
  • Interactive Panel Webinar: Bioanalytical Testing for Gene Therapy
  • Large Molecule Pharmacokinetic Assays for New Modalities
  • MicroConstants is now BioAgilytix San Diego
  • Multiparameter Flow Cytometry as a Powerful Tool in Drug Development
  • PK Assessment for Advanced Modalities (Cell & Gene Therapies
  • PK Assessment for Advanced Modalities (Cell & Gene Therapies)
  • Platform Usage to Support Advanced Drug Modalities
  • Potency Assays for ATMPs – Conception, Development, Validation, Matrixed Approaches and Assay Lifecycle
  • Potency Assays For Gene & Cell Therapy Products
  • Strategies for Overcoming Drug Interference in Immunogenicity Assessment
  • TEMPLATE – Registration Page
  • Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge
  • Total Bioanalytical Support for Antibody-Drug Conjugates (ADCs)
  • Translational Medicine in Drug Development – How to Implement a Biomarker Strategy in a Clinical Trial
• Cookie Preferences
• Das Biosimilar-Paradoxon auflösen
• Executive Leadership
• Newsletter
• Privacy Policy
• Recruitment Fraud Notice
• Scientific Expertise
  • Posters
  • Project Management
  • Publications
  • Scientific Insights
    • Case Studies
    • Molecular Moments Podcast
    • Science in 60 Videos
    • Webinars
    • 14th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
    • 15th Japan BioanalysisForum Symposium
    • 16th EBF Open Symposium
    • 17th WRIB: Where Regulators & Industry Convene
    • 17th WRIB: Where Regulators & Industry Convene
    • 25th International Society for the Study of Xenobiotics (ISSX) North American Meeting
    • 5th Annual Gene Therapy Analytical Development Summit 2023
    • AAPS: PharmSci 360
    • American College of Toxicology (ACT) 44th Annual Meeting
    • CASSS WCBP 2024
    • CHI: Immunogenicity & Bioassay Summit
    • Enhancing Throughput of In Vitro DDI Assays with Echo® MS+ Platform – PBSS 2024
    • European Society of Gene and Cell Therapy Annual Congress (ESGCT) 30th Annual Congress
    • National Biotechnology Conference
    • Post-Event Landing Page
    • TEMPLATE – Ungated eBook / Whitepaper Download
  • Scientific Office
• Solutions
  • Capabilities
    • Assay Creation
      • Protein Binding Assays
    • Diagnostic Testing
      • Holiday Closures
    • Kit Production
    • Method Transfer
    • Off-the-Shelf Assay Menu
    • Off-the-Shelf Assays
    • Sample Analysis
  • Modalities
    • Advanced Therapies (ATMP)
      • CAR T-Cell Therapies
      • Cell Therapy
      • Gene Therapy
    • Large Molecules
      • ADC Testing
      • Biosimilars
      • Monoclonal Antibodies
    • Small Molecules
      • Drug-Drug Interactions
      • Non-Proprietary Assay List
    • Vaccines
  • Phases
    • Clinical
      • Australian Advantage
    • CMC Bioanalytical Development
    • Discovery
    • Preclinical
      • Dose Formulation Analysis
      • Toxicology Support
  • Services
    • Biomarkers
    • Chemistry, Manufacturing, & Controls (CMC)
      • Dose Formulation Analysis
    • Consulting Services
    • Drug Metabolism
    • Immunogenicity
      • ADA
      • Cytokines
      • NAb Assays
    • Pharmacodynamics
    • Pharmacokinetics
      • PK Assay Analysis and Reports
• Speak to a Scientist
• Techniques & Platforms
  • Instrumentation
    • Biacore
    • ELISpot
    • Flow Cytometers
    • Gyrolab
    • ImmunoCAP
    • LI-COR
    • Luminex
    • Mass Spectrometry
    • MSD
    • PCR
    • Plate Readers
    • Protein Simple Ella
    • Roche Cobas Analyzer
  • Lab Automation Systems
  • Quality Systems
    • Critical Reagents
    • Sample Management
  • Techniques
    • Cell-Based Assays
      • Cell-Based Potency Assays
      • Flow Cytometry
    • Ligand Binding Assay / Immunoassay
    • Mass Spectrometry
    • Molecular Assays
    • Virology
• Terms Of Use
• Therapeutic Focus
  • Autoimmune
  • Immuno-oncology
  • Metabolic Disease
  • Neurology
  • Oncology
  • Virology
• This is not the article for you
• Virtual Laboratory Tours
  • Australia Tour
  • Boston Tour
  • Durham Tour
  • Germany Tour
  • Morrisville, NC Tour
  • San Diego
• ADC Case Studies: Overcoming Challenges in Bioanalytical and CMC Characterization